Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Samy Majoul is active.

Publication


Featured researches published by Samy Majoul.


Journal of Biotechnology | 2002

Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.

Héla Kallel; Ahlem Jouini; Samy Majoul; Samia Rourou

We have carried out the adaptation of BHK-21 cells to two serum free (Ex Cell 520 and HyQ PF CHO) and three animal protein free media: Ex Cell 302, HyQ PF CHO MPS and Rencyte BHK. After a direct switch or a gradual adaptation, we have achieved BHK-21 cells growth in the following media: HyQ PF CHO, HyQ PF CHO MPS, Rencyte BHK and Ex Cell 302. The most suitable media for BHK-21 cells growth, with respect to cell density and specific growth rate, were HyQ PF CHO and HyQ PF CHO MPS. Hence we have selected these media to study cell growth and the production of rabies virus. Kinetic studies of cell growth in spinner flasks using the selected media have shown that a maximal cell density of 2x10(6) cells x ml(-1) was reached in both media. For rabies virus production, the viral titer obtained was 1.7x10(6) FFU x ml(-1) in HyQ PF CHO as well as in HyQ PF CHO MPS medium. The optimization of rabies virus production by BHK-21 cells grown in a 2 l bioreactor using the selected media, pointed to the following parameters: culture mode, perfusion rate and multiplicity of infection (MOI), as being the critical factors for achieving a good virus yield. When tested in mice, the activity of the experimental vaccines prepared on HyQ PF CHO MPS medium has shown a protective activity that meets WHO requirements.


Vaccine | 2014

An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines

Samia Rourou; Yousr Ben Ayed; Khaled Trabelsi; Samy Majoul; Héla Kallel

IPT-AFM is a proprietary animal component free medium that was developed for rabies virus (strain LP 2061) production in Vero cells. In the present work, we demonstrated the versatility of this medium and its ability to sustain the growth of other cell lines and different virus strains. Here, three models were presented: Vero cells/rabies virus (strain LP 2061), MRC-5 cells/measles virus (strain AIK-C) and BHK-21 cells/rabies virus (strain PV-BHK21). The cell lines were first adapted to grow in IPT-AFM, by progressive reduction of the amount of serum in the culture medium. After their adaptation, BHK-21 cells grew in suspension by forming clumps, whereas MRC-5 cells remained adherent. Then, kinetics of cell growth were studied in agitated cultures for both cell lines. In addition, kinetics of virus replication were investigated.


Archive | 2003

DEVELOPMENT OF A NOVEL PROCESS TO PRODUCE A VETERINARY RABIES VACCINE IN BHK-21 CELLS GROWN ON MICROCARRIERS IN A 20 LITER BIOREACTOR

Samia Rourou; Samy Majoul; Houssem Loukil; Héla Kallel

We studied BHK-21 cells growth in a 2 liter bioreactor and investigated the effects of microcarriers concentration, nature of growth medium, culture mode and serum concentration. We have reached a cell density of 4×106 cells/ml under the following growth conditions: Medium: MEM supplemented with Hank’s salts, non essential amino acids and 5% FCS, Culture mode: perfusion, Microcarriers concentration: 4 g/l of Cytodex 3


Archive | 2001

Assay of Serum and Animal Protein Free Media for the Production of a Veterinary Rabies Vaccine by BHK-21 Cells

Ahlem Jouini; Samy Majoul; Samia Rourou; Héla Kallel

Rabies encephalo-myelitis is often fatal. Sixty thousand death and 10 millions post-exposure treatment are reported yearly among human. This viral infection remains a serious public health concern particularly in developing countries where dog, especially stray dog, is the main reservoir. Thus, mass vaccination of dogs seems to be the best way to prevent the contamination of man in these countries.


Journal of Biotechnology | 2006

Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor

Khaled Trabelsi; Samia Rourou; Houssem Loukil; Samy Majoul; Héla Kallel


Enzyme and Microbial Technology | 2005

Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor

Khaled Trabelsi; Samia Rourou; Houssem Loukil; Samy Majoul; Héla Kallel


Applied Microbiology and Biotechnology | 2009

A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor

Samia Rourou; Arno van der Ark; Samy Majoul; Khaled Trabelsi; Tiny van der Velden; Héla Kallel


Applied Microbiology and Biotechnology | 2012

Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor

Khaled Trabelsi; Samy Majoul; Samia Rourou; Héla Kallel


Applied Microbiology and Biotechnology | 2003

A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor

Héla Kallel; Samia Rourou; Samy Majoul; Houssem Loukil


Applied Microbiology and Biotechnology | 2013

Proteome analysis of virus–host cell interaction: rabies virus replication in Vero cells in two different media

Sabine Kluge; Samia Rourou; Diana Vester; Samy Majoul; Dirk Benndorf; Yvonne Genzel; Erdmann Rapp; Héla Kallel; Udo Reichl

Collaboration


Dive into the Samy Majoul's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dirk Benndorf

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sabine Kluge

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar

Udo Reichl

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge